CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-14 | Kummerfeld Keith C See Remarks | Option exercise · Employee Stock Option (right to buy) | −1,031 | 7,938 | ||
| 2023-07-03 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $28.75 | $144K | 544,448 |
| 2023-06-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $27.16 | $136K | 549,448 |
| 2023-05-11 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −7,925 | $30.24 | $240K | 554,448 |
| 2023-05-10 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −17,075 | $30.00 | $512K | 562,373 |
| 2023-05-01 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $25.93 | $130K | 579,448 |
| 2023-04-18 | Kummerfeld Keith C See Remarks | Option exercise | +1,031 | $14.12 | $15K | 1,981 |
| 2023-04-18 | Kummerfeld Keith C See Remarks | Option exercise | +4,500 | $9.04 | $41K | 6,481 |
| 2023-04-18 | Kummerfeld Keith C See Remarks | Option exercise | +1,437 | $4.99 | $7K | 7,918 |
| 2023-04-18 | Kummerfeld Keith C See Remarks | Sale | −6,968 | $28.18 | $196K | 950 |
| 2023-04-17 | Kummerfeld Keith C See Remarks | Option exercise · Employee Stock Option (right to buy) | −1,031 | 8,969 | ||
| 2023-04-17 | Kummerfeld Keith C See Remarks | Option exercise · Employee Stock Option (right to buy) | −4,500 | 25,500 | ||
| 2023-04-17 | Kummerfeld Keith C See Remarks | Option exercise · Employee Stock Option (right to buy) | −1,437 | 8,563 | ||
| 2023-04-03 | Chivukula Pad Chief Scientific Officer & COO | Sale 10b5-1 | −5,000 | $25.38 | $127K | 584,448 |
| 2023-03-06 | Chivukula Pad Chief Scientific Officer & COO | Sale | −5,000 | $16.07 | $80K | 589,448 |
| 2022-12-15 | Marquet Magda Director | Purchase | +2,222 | $18.00 | $40K | 24,942 |
| 2022-12-09 | Kummerfeld Keith C See Remarks | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-12-09 | SASSINE ANDY Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-12-09 | Payne Joseph E President and CEO | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2022-12-09 | Chivukula Pad Chief Scientific Officer & COO | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 |
Page 5 of 9 · 178 trades